CD47 and breast cancer: A recent study from Semenza’s group showed that HIF-1α activated transcription of CD47 in mesenchymal triple-negative primary breast cancer cells (SUM159) and promoted the breast cancer stem cell phenotype, which further protected cancer cells from phagocytosis by bone marrow-derived macrophages (53).